These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 2498131

  • 1. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography.
    Donnez J, Schrurs B, Gillerot S, Sandow J, Clerckx F.
    Fertil Steril; 1989 Jun; 51(6):947-50. PubMed ID: 2498131
    [Abstract] [Full Text] [Related]

  • 2. Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
    Nakamura Y, Yoshimura Y.
    Clin Obstet Gynecol; 1993 Sep; 36(3):660-7. PubMed ID: 8403612
    [No Abstract] [Full Text] [Related]

  • 3. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study.
    Maheux R, Guilloteau C, Lemay A, Bastide A, Fazekas AT.
    Am J Obstet Gynecol; 1985 Aug 15; 152(8):1034-8. PubMed ID: 3927734
    [Abstract] [Full Text] [Related]

  • 4. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
    Healy DL, Lawson SR, Abbott M, Baird DT, Fraser HM.
    J Clin Endocrinol Metab; 1986 Sep 15; 63(3):619-25. PubMed ID: 3090092
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential reduction in the volume of leiomyoma and uterus during buserelin treatment.
    Puzigaća Z, Prelević GM, Sretenović Z.
    Gynecol Endocrinol; 1994 Mar 15; 8(1):39-43. PubMed ID: 8059616
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Subcutaneous injection or infusion of gonadotropin releasing-hormone agonist buserelin in the treatment of enlarged uteri harboring leiomyomata.
    Franssen AM, Willemsen WN, Corbey RS, Doesburg WH, van 't Veen AJ, Rolland R.
    Eur J Obstet Gynecol Reprod Biol; 1991 Jul 25; 40(3):221-8. PubMed ID: 1908799
    [Abstract] [Full Text] [Related]

  • 9. Use of gonadotropin-releasing hormone agonists before myomectomy.
    Friedman AJ.
    Clin Obstet Gynecol; 1993 Sep 25; 36(3):650-9. PubMed ID: 8403611
    [No Abstract] [Full Text] [Related]

  • 10. Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.
    Costantini S, Anserini P, Valenzano M, Remorgida V, Venturini PL, De Cecco L.
    Eur J Obstet Gynecol Reprod Biol; 1990 Oct 25; 37(1):63-9. PubMed ID: 2142921
    [Abstract] [Full Text] [Related]

  • 11. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
    Andreyko JL, Blumenfeld Z, Marshall LA, Monroe SE, Hricak H, Jaffe RB.
    Am J Obstet Gynecol; 1988 Apr 25; 158(4):903-10. PubMed ID: 2966587
    [Abstract] [Full Text] [Related]

  • 12. Uterine leiomyoma: treatment with LHRH agonist.
    Maheux R, Lemay A.
    Prog Clin Biol Res; 1986 Apr 25; 225():297-311. PubMed ID: 3097669
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist].
    Nakamura Y, Yoshimura Y, Yamada H, Maruyama K, Nanno T, Ubukata Y, Ando M, Takahashi K, Suzuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec 25; 42(12):1620-6. PubMed ID: 2126024
    [Abstract] [Full Text] [Related]

  • 15. Neodymium: YAG laser hysteroscopy in large submucous fibroids.
    Donnez J, Gillerot S, Bourgonjon D, Clerckx F, Nisolle M.
    Fertil Steril; 1990 Dec 25; 54(6):999-1003. PubMed ID: 2245860
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
    Letterie GS, Coddington CC, Winkel CA, Shawker TH, Loriaux DL, Collins RL.
    Fertil Steril; 1989 Jun 25; 51(6):951-6. PubMed ID: 2498132
    [Abstract] [Full Text] [Related]

  • 17. Uterine leiomyoma and LHRH agonist treatment. A preliminary report.
    Rolland R, Franssen AM, Willemsen WN, Corbey RS.
    Prog Clin Biol Res; 1986 Jun 25; 225():313-20. PubMed ID: 3097670
    [No Abstract] [Full Text] [Related]

  • 18. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
    Fernández-Montolí ME, Díez-Gibert O, Samaniego JM, Balagueró L, Navarro MA.
    Fertil Steril; 1995 Mar 25; 63(3):522-7. PubMed ID: 7851581
    [Abstract] [Full Text] [Related]

  • 19. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
    Nakamura Y, Yoshimura Y, Yamada H, Ubukata Y, Ando M, Suzuki M.
    Fertil Steril; 1991 May 25; 55(5):900-5. PubMed ID: 1902420
    [Abstract] [Full Text] [Related]

  • 20. Dose-related inhibition of acute luteinizing hormone response during luteinizing hormone-releasing hormone agonist treatment for uterine leiomyoma.
    Maheux R, Lemay A, Turcot-Lemay L.
    Am J Obstet Gynecol; 1988 Feb 25; 158(2):361-4. PubMed ID: 3124621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.